22065S006 Ixempra - Ixabepilone Clinical PREA - Ixabepilone - Document - PDFSEARCH.IO

First Page		Document Content
Health Response Evaluation Criteria in Solid Tumors Neuroblastoma Ixabepilone Clinical trial TH-302 Medicine Brain tumor Oncology		22065S006 Ixempra - Ixabepilone Clinical PREA Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 447,20 KB Share Document on Facebook

	1. Sautter BM, Wessely R, Bihl H. Comparison of systemic radiotherapy with I-131labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts. Strahlenther Onkol 1993;169:. DocID: 1ukO2 - View Document
	Numeric Key of Factor levels for extraction parameters Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development – A Systematic Review Marianne Isabelle Martic-Kehl, DocID: 1qWRv - View Document
	ANTI-TROPOMYOSIN AGENTS ENHANCE THE ANTITUMOR EFFECTIVENESS OF MICROTUBULE INHIBITORS IN PRECLINICAL MODELS OF NEUROBLASTOMA. JUSTINE STEHN1,2, MARK CURRIER3, DUO CHEN3, BROOKE NARTKER3, ELEANOR EIFFE1, ANDREW HEATON1,2, DocID: 1qUPq - View Document
	www.edoriumjournals.com CASE REPORT PEER REVIEWED \| OPEN ACCESS DocID: 1qNSk - View Document
	May 2016 29th April, 2015 INVESTOR FACT SHEET Business Summary Novogen is a drug development company focused on DocID: 1qNjw - View Document